Opinion · Supreme Court of the United States

Stamps v. Collagen Corp

Stamps v. Collagen Corp, 510 U.S. 824 (1993)

Type
Opinion
Court
Supreme Court of the United States
Jurisdiction
Federal
Date
1993-10-04
Topic
general

How later courts describe this case

  • holding that existence of express preemption clause precludes reliance on implied preemption doctrine, without determining whether provision constituted a "reliable indicium of congressional intent"
  • holding that the analysis used in Ferebee did not survive the Cipollone decision
  • holding that the analysis used in Fer-ebee did not survive the Cipollone decision
  • finding that the express preemption provision in the MDA precludes any discussion regarding implied preemption
  • holding state law claims not preempted where FDA had established no specific requirements unique to the Class III medical device at issue
  • finding that the PMA process constitutes a “specific requirement” applicable to a particular device
  • “[W]e do not believe the [preemption] analysis [in Ferebee] can be said to have survived Cipollone-”
  • claims of failure to warn and defective design preempted where manufacturer of Class III device underwent PMA

Citator

UpLaw has not yet analyzed Stamps v. Collagen Corp. The absence of a flag is not a finding that it is good law.

Cited by
94 opinions

510 U.S. 824

Stamps
v.
Collagen Corp.

No. 92-1989.

Supreme Court of United States.

October 4, 1993.

1

Appeal from the C. A. 5th Cir.

2

Certiorari denied. Reported below: 984 F. 2d 1416.